Skip to content

Mindfulness instruction for medication adherence among adolescents and young adults living with HIV: a randomized controlled trial.

Erica Sibinga, Lindsey Webb, Jamie Perin, Vicki Tepper, Deanna Kerrigan, Suzanne M. Grieb, Julie Denison, Jonathan M. Ellen

AIDS Care December 2022 DOI: 10.1080/09540121.2022.2105796 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Longitudinal Peer reviewed
Sample size 74
Population Adolescents and young adults (AYA) 13-24 years old living with HIV (AYALH)
Interventions Mindfulness-based stress reduction (MBSR) general health education (HT)
Duration Nine sessions; data collected at baseline, post-program (3 months), 6 and 12 months
Topics Meditation
Keywords Adolescents Hiv Adherence Youth
Key findings Post-program, MBSR participants had greater increases in medication adherence (p = 0.001) and decreased HIV viral load (p = 0.052) compared with health education. MBSR participants showed decreased mindfulness at follow-up. The authors suggest MBSR may play a role in improving HIV medication adherence and decreasing HIV viral load in this population.

Abstract

Adolescents and young adults (AYA) 13-24 years old make up a disproportionate 21% of new HIV diagnoses. Unfortunately, they are less likely to treat HIV effectively, with only 30% achieving viral suppression, limiting efforts to interrupt HIV transmission. Previous work with mindfulness-based stress reduction (MBSR) has shown promise for improving treatment in AYA living with HIV (AYALH). This randomized controlled trial compared MBSR with general health education (HT). Seventy-four 13-24-year-old AYALH conducted baseline data collection and were randomized to nine sessions of MBSR or HT. Data were collected at baseline, post-program (3 months), 6 and 12 months on mindfulness and HIV management [medication adherence (MA), HIV viral load (HIV VL), and CD4]. Longitudinal analyses were conducted. The MBSR arm reported higher mindfulness at baseline. Participants were average 20.5 years old, 92% non-Hispanic Black, 51% male, 46% female, and 3% transgender. Post-program, MBSR participants had greater increases than HT in MA (p = 0.001) and decreased HIV VL (p = 0.052). MBSR participants showed decreased mindfulness at follow-up. Given the significant challenges related to HIV treatment in AYALH, these findings suggest that MBSR may play a role in improving HIV MA and decreasing HIV VL. Additional research is merited to investigate MBSR further for this important population.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics